Vaishali Pharma Q1 FY27 results: PAT up, revenue dips YoY

Revenue declinedResults View source PDF Explain this filing

VAISHALI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹8.44

prior close

₹8.84

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-1.1% vs market

Pharmaceuticals peers, median of 167sector-0.3%-0.6% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.8

15m

-1.0

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+0.1-1.1-0.3-0.6

Next day

+0.6+0.5+0.1-0.0+0.6

-2.7-0.1-2.6-0.7-2.0

-5.3+0.4-5.8-0.4-4.9

-5.2+0.7-5.9-0.7-4.6

-5.2+0.9-6.2-0.5-4.7

-3.3+1.1-4.4-0.7-2.6

15d

-0.6+1.6-2.2+1.4-2.0

+4.5-0.7+5.2+0.4+4.1

-11.1-3.2-7.9-4.1-7.0

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 (June 30, 2026) results. Revenue from operations fell to Rs 2,289.14 lacs vs Rs 2,374.71 lacs in Q1 FY26. Profit after tax rose to Rs 148.97 lacs from Rs 127.93 lacs. EPS stood at Rs 0.11. Consolidated PAT was Rs 154.62 lacs including Rs 5.65 lacs from associate Kesar Pharma. AGM set for September 24, 2026.

Likely market impact

Mixed quarter: revenue dipped YoY while profit grew modestly. Watch for margin trend in coming quarters.